Song LL, Wang N, Zhang JP, Yu LP, Chen XP, Zhang B, Yang WY. Postprandial glucagon-like peptide 1 secretion is associated with urinary albumin excretion in newly diagnosed type 2 diabetes patients. World J Diabetes 2023; 14(3): 279-289 [PMID: 37035218 DOI: 10.4239/wjd.v14.i3.279]
Corresponding Author of This Article
Wen-Ying Yang, MD, Professor, Department of Endocrinology, China-Japan Friendship Hospital, No. 2 Yinghua East Street, Chaoyang District, Beijing 100029, China, ywy_1010@163.com
Research Domain of This Article
Endocrinology & Metabolism
Article-Type of This Article
Clinical Trials Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Share the Article
Song LL, Wang N, Zhang JP, Yu LP, Chen XP, Zhang B, Yang WY. Postprandial glucagon-like peptide 1 secretion is associated with urinary albumin excretion in newly diagnosed type 2 diabetes patients. World J Diabetes 2023; 14(3): 279-289 [PMID: 37035218 DOI: 10.4239/wjd.v14.i3.279]
World J Diabetes. Mar 15, 2023; 14(3): 279-289 Published online Mar 15, 2023. doi: 10.4239/wjd.v14.i3.279
Postprandial glucagon-like peptide 1 secretion is associated with urinary albumin excretion in newly diagnosed type 2 diabetes patients
Lu-Lu Song, Na Wang, Jin-Ping Zhang, Li-Ping Yu, Xiao-Ping Chen, Bo Zhang, Wen-Ying Yang
Lu-Lu Song, Na Wang, Jin-Ping Zhang, Li-Ping Yu, Xiao-Ping Chen, Bo Zhang, Wen-Ying Yang, Department of Endocrinology, China-Japan Friendship Hospital, Beijing 100029, China
Author contributions: Song LL analyzed the data the data and drafted the manuscript; Zhang JP and Wang N collected the data and performed the literature review; Yu LP provides ideas and commentary in the process of writing the article; Chen XP and Zhang B coordinated the implementation of the study; Yang WY was the principal investigator of the study; and all authors have read and approved the final manuscript.
Institutional review board statement: The study was reviewed and approved China-Japan Friendship Hospital Institutional Review Board (Approval No. 2008-23).
Clinical trial registration statement: This trial was registered at ChiCTR (registration: No. ChiCTR-TRC-08000231).
Informed consent statement: All study participants, or their legal guardian, provided informed written consent prior to study enrollment.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Data sharing statement: No additional data are available.
CONSORT 2010 statement: The authors have read the CONSORT 2010 statement, and the manuscript was prepared and revised according to the CONSORT 2010 statement.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Wen-Ying Yang, MD, Professor, Department of Endocrinology, China-Japan Friendship Hospital, No. 2 Yinghua East Street, Chaoyang District, Beijing 100029, China, ywy_1010@163.com
Received: October 27, 2022 Peer-review started: October 27, 2022 First decision: December 12, 2022 Revised: December 21, 2022 Accepted: February 16, 2023 Article in press: February 16, 2023 Published online: March 15, 2023 Processing time: 139 Days and 14 Hours
Core Tip
Core Tip: The association between the microalbuminuria and glucagon-like peptide 1 (GLP-1) response after a standard meal load in newly diagnosed Chinese type 2 diabetes mellitus patients was identified. Patients with microalbuminuria showed lower postprandial GLP-1 levels than those without microalbuminuria. The prevalence of microalbuminuria decreased with increasing quartiles of 30 min and 120 min and area under the curve for active GLP-1 levels after a standard meal. The highlights of our study are that the patients were newly diagnosed, which excluded the influence of glucose-lowering therapies. Furthermore, we assessed the fasting and postprandial GLP-1 levels in response to a standard meal, not oral glucose. Third, the GLP-1 determined in our study was active GLP-1, not total GLP-1.
